XBRL Proof

XBRL File

Document - Document and Entity Information

Document - Document and Entity Information (USD $)	12 Months Ended
( custom:DocumentAndEntityInformationAbstract [Extension] )
	Dec. 31, 2015	Jun. 30, 2014	Mar. 27, 2015



Entity Registrant Name	Artventive Medical Group, Inc.
( dei:EntityRegistrantName )
Entity Central Index Key	0001405249
( dei:EntityCentralIndexKey )
Document Type	10-K
( dei:DocumentType )
Document Period End Date	2015-12-31
( dei:DocumentPeriodEndDate )
Amendment Flag	false
( dei:AmendmentFlag )
Current Fiscal Year End Date	--12-31
( dei:CurrentFiscalYearEndDate )
Is Entity a Well-known Seasoned Issuer?	No
( dei:EntityWellKnownSeasonedIssuer )
Is Entity a Voluntary Filer?	Yes
( dei:EntityVoluntaryFilers )
Is Entity's Reporting Status Current?	No
( dei:EntityCurrentReportingStatus )
Entity Filer Category	Smaller Reporting Company
( dei:EntityFilerCategory )
Entity Public Float		34,776,286
( dei:EntityPublicFloat )
Entity Common Stock, Shares Outstanding			60,006,286
( dei:EntityCommonStockSharesOutstanding )
Document Fiscal Period Focus	FY
( dei:DocumentFiscalPeriodFocus )
Document Fiscal Year Focus	2014
( dei:DocumentFiscalYearFocus )

(End Document - Document and Entity Information)

Statement - Balance Sheets

Statement - Balance Sheets (USD $)
( us-gaap:StatementOfFinancialPositionAbstract )
	Dec. 31, 2014		Dec. 31, 2013





current
( us-gaap:AssetsCurrentAbstract )
Cash and cash equivalents	104,030		1,626,521
( us-gaap:CashAndCashEquivalentsAtCarryingValue )
Accounts receivable	22,662		�
( us-gaap:AccountsReceivableNet )
Prepaid expenses	1,048		9,098
( us-gaap:PrepaidExpenseCurrent )
Inventory	23,738		26,903
( us-gaap:InventoryGross )
Total current assets	151,478		1,662,522
( us-gaap:AssetsCurrent )
Property, plant and equipment
( us-gaap:PropertyPlantAndEquipmentAbstract )
Office equipment	17,953		16,380
( us-gaap:PropertyPlantAndEquipmentOther )
Accumulated Depreciation	(5,467	)	(2,303	)
( us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment )
net property, plant and equipment	12,486		14,077
( us-gaap:PropertyPlantAndEquipmentNet )
OTHER ASSETS
( us-gaap:OtherAssetsAbstract )
Deposits	25,007		51,048
( us-gaap:Deposits )
TOTAL OTHER ASSETS	25,007		51,048
( us-gaap:OtherAssets )


Total assets	188,971		1,727,647
( us-gaap:Assets )


Liabilities and stockholders’ EQUITY
( us-gaap:LiabilitiesAndStockholdersEquityAbstract )
current
( us-gaap:LiabilitiesCurrentAbstract )
Accounts payable	221,397		272,509
( us-gaap:AccountsPayableCurrent )
Accrued expenses	1,043,300		585,800
( us-gaap:AccruedLiabilitiesCurrent )
Payroll taxes payable	�		�
( us-gaap:AccruedPayrollTaxesCurrent )
Total current liabilities	1,264,697		858,309
( us-gaap:LiabilitiesCurrent )
LONG-TERM LIABILITIES
( us-gaap:LongTermDebtAbstract )
Notes payable	500,000		�
( us-gaap:NotesPayable )
TOTAL LONG-TERM LIABILITIES	500,000		�
( us-gaap:LongTermDebtNoncurrent )


TOTAL LIABILITIES	1,764,697		858,309
( us-gaap:AccruedLiabilitiesCurrentAndNoncurrent )


stockholders’ equity
( us-gaap:StockholdersEquityAbstract )


Common stock, par value $.001, 100,000,000 shares authorized, 59,506,286 and 55,306,286 shares issued and outstanding at December 31, 2014 and December 31, 2013 respectively	59,506		55,306
( us-gaap:CommonStockParOrStatedValuePerShare )
Additional paid in capital	12,879,982		9,056,279
( us-gaap:AdditionalPaidInCapital )
Deficit accumulated during the development stage	(14,515,214	)	(8,242,247	)
( us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage )
TOTAL STOCKHOLDERS’ EQUITY	(1,575,726	)	869,338
( us-gaap:StockholdersEquity )
TOTAL LIABILITIES AND STOCKHOLDER’S EQUITY	188,971		1,727,647
( us-gaap:LiabilitiesAndStockholdersEquity )

(End Statement - Balance Sheets)

Statement - Balance Sheets (Parenthetical)

Statement - Balance Sheets (Parenthetical) (USD $)
( us-gaap:StatementOfFinancialPositionAbstract )
	Dec. 31, 2014	Dec. 31, 2013





Common stock, par value $.001, shares authorized	100,000,000	100,000,000
( us-gaap:CommonStockSharesAuthorized )
Common stock, par value $.001, shares issued and outstanding	0	869,338
( us-gaap:CommonStockSharesIssued )

(End Statement - Balance Sheets (Parenthetical))

Statement - Statements of Operations

Statement - Statements of Operations (USD $)	12 Months Ended
( us-gaap:IncomeStatementAbstract )
	Dec. 31, 2014		Dec. 31, 2013









revenues	111,732		0
( us-gaap:Revenues )
COST OF GOODS SOLD	111,732		0
( us-gaap:CostOfGoodsSold )
GROSS PROFIT	�		�
( us-gaap:GrossProfit )
operating expenses
( us-gaap:OperatingExpensesAbstract )
Exploration costs	�		�
( us-gaap:ExplorationCosts )
Research and development	3,127,850		2,046,796
( us-gaap:ResearchAndDevelopmentExpense )
Selling, general and administrative	3,142,652		1,448,821
( us-gaap:SellingGeneralAndAdministrativeExpense )
Depreciation expense	3,164		1,460
( us-gaap:Depreciation )
Operating loss before other items and income taxes	(6,273,666	)	(3,497,077	)
( us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic )
Other income
( us-gaap:OtherIncomeAndExpensesAbstract )
Interest income	699		786
( us-gaap:InterestAndDividendIncomeOperating )
Income taxes	�		�
( us-gaap:IncomeTaxesPaid )
net loss availAble to common stockholders	(6,272,967	)	(3,496,291	)
( us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic )
COMPREHENSIVE LOSS FOR THE PERIOD	(6,272,967	)	(3,496,291	)
( us-gaap:ComprehensiveIncomeNetOfTax )
basic and diluted loss per common share	0		0
( us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare )
weighted average shares outstanding	57,352,546		52,346,677
( us-gaap:WeightedAverageBasicSharesOutstandingProForma )

(End Statement - Statements of Operations)

Statement - Statements of Cash Flows

Statement - Statements of Cash Flows (USD $)	12 Months Ended
( us-gaap:StatementOfCashFlowsAbstract )
	Dec. 31, 2014		Dec. 31, 2013



cash flow from operating activities
( us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract )
Net loss	(6,272,967	)	(3,496,291	)
( us-gaap:NetIncomeLoss )
Adjustments to reconcile net loss to net cash used by operating activities
( us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract )


Non-cash expenses	�		�
( us-gaap:OtherNoncashIncomeExpense )
Depreciation expense	3,164		1,460
( us-gaap:DepreciationAndAmortization )
Issuance of common stock and options for services	47,903		24,733
( us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities )
Changes in operating assets and liabilities
( us-gaap:IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract )
Accounts receivable	(22,662	)	�
( us-gaap:IncreaseDecreaseInAccountsReceivable )
Prepaid expenses	8,050		(3,050	)
( us-gaap:IncreaseDecreaseInPrepaidExpense )
Inventory	3,165		(26,903	)
( us-gaap:IncreaseDecreaseInInventories )
Deposits	26,041		�
( us-gaap:IncreaseDecreaseInDeposits )
Accounts payable	(51,112	)	262,459
( us-gaap:IncreaseDecreaseInAccountsPayable )
Payroll taxes payable	�		(84	)
( us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities )
Accrued expenses	37,500		�
( us-gaap:IncreaseDecreaseInAccruedLiabilities )
Net cash used by operating activities	(6,220,918	)	(3,237,676	)
( us-gaap:NetCashProvidedByUsedInContinuingOperations )
cash flows from investing activities
( us-gaap:NetCashProvidedByUsedInInvestingActivitiesAbstract )
Purchase of equipment	(1,573	)	(11,634	)
( us-gaap:PaymentsToAcquirePropertyPlantAndEquipment )
NET CASH used BY INVESTING ACTIVITIES	(1,573	)	(11,634	)
( us-gaap:NetCashProvidedByUsedInInvestingActivities )
cash flows from financing activities
( us-gaap:NetCashProvidedByUsedInFinancingActivitiesAbstract )
Issuance of common stock for cash	4,200,000		4,358,000
( us-gaap:ProceedsFromIssuanceOrSaleOfEquity )
Issuance of notes payable	500,000		�
( us-gaap:ProceedsFromNotesPayable )
Convertible note payable (see Note 5)	�		�
( us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature )
NET CASH PROVIDED BY FINANCING ACTIVITIES	4,700,000		4,358,000
( us-gaap:NetCashProvidedByUsedInFinancingActivities )
net increase (decrease) in cash and cash equivalents	(1,522,491	)	1,108,690
( us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease )
cash, beginning of period	1,626,521		517,831
( us-gaap:Cash )
cash, end of period	104,030		1,626,521
( us-gaap:Cash )
Cash paid during the year:
( us-gaap:SupplementalCashFlowInformationAbstract )
Interest paid	�		�
( us-gaap:InterestPaid )
Income taxes paid	�		�
( us-gaap:IncomeTaxesPaidNet )
ACCRUAL OF STOCK ISSUANCE COST	420,000		435,800
( us-gaap:PaymentsOfStockIssuanceCosts )

(End Statement - Statements of Cash Flows)

Statement - Shareholders Equity

Statement - Shareholders Equity (USD $)
( us-gaap:StatementOfStockholdersEquityAbstract )
	Common Stock	Additional Paid-In Capital		Retained Earnings / Accumulated Deficit		Other Comprehensive Income / Loss	<Total>
( us-gaap:StatementEquityComponentsAxis )

( us-gaap:EquityComponentDomain )
From Jan. 1, 2012 to Dec. 31, 2012

Common shares issued in private placement	0	0		0		0	0
( us-gaap:StockIssuedDuringPeriodValueNewIssues )
Common shares issued in private placement, in shares	0	0		0		0	0
( us-gaap:StockIssuedDuringPeriodSharesNewIssues )
Common shares to be issued as finder's fee	0	0		0		0	0
( us-gaap:StockIssuedDuringPeriodValueOther )
Stock options issued for services	0	0		0		0	0
( us-gaap:EmployeeBenefitsAndShareBasedCompensation )
Loss during year	0	0		0		0	0
( us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted )
Balance	50,949	5,113,703		(4,745,956	)	�	418,696
( us-gaap:StockholdersEquity )
Balance, in shares	50,948,286	0		0		0	0
( us-gaap:CommonStockSharesIssued )
From Jan. 1, 2013 to Dec. 31, 2013

Common shares issued in private placement	4,357	4,353,643		0		0	4,358,000
( us-gaap:StockIssuedDuringPeriodValueNewIssues )
Common shares issued in private placement, in shares	4,358,000	0		0		0	0
( us-gaap:StockIssuedDuringPeriodSharesNewIssues )
Common shares to be issued as finder's fee	0	(435,800	)	0		0	(435,800	)
( us-gaap:StockIssuedDuringPeriodValueOther )
Stock options issued for services	0	24,733		0		0	24,733
( us-gaap:EmployeeBenefitsAndShareBasedCompensation )
Loss during year	0	0		(3,496,291	)	0	(3,496,291	)
( us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted )
Balance	55,306	9,056,279		(8,242,247	)	0	869,338
( us-gaap:StockholdersEquity )
Balance, in shares	55,306,286	0		0		0	869,338
( us-gaap:CommonStockSharesIssued )
From Jan. 1, 2014 to Dec. 31, 2014

Common shares issued in private placement	4,200	4,195,800		0		0	4,200,000
( us-gaap:StockIssuedDuringPeriodValueNewIssues )
Common shares issued in private placement, in shares	4,200,000	0		0		0	0
( us-gaap:StockIssuedDuringPeriodSharesNewIssues )
Common shares to be issued as finder's fee	0	(420,000	)	0		0	(420,000	)
( us-gaap:StockIssuedDuringPeriodValueOther )
Stock options issued for services	0	47,903		0		0	47,903
( us-gaap:EmployeeBenefitsAndShareBasedCompensation )
Loss during year	0	0		(6,272,967	)	0	(6,272,967	)
( us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted )
Balance	59,506	12,879,982		(14,515,214	)	0	(1,575,726	)
( us-gaap:StockholdersEquity )
Balance, in shares	59,506,286	0		0		0	0
( us-gaap:CommonStockSharesIssued )

(End Statement - Shareholders Equity)

Disclosure - Basis of Financial Statement Presentation

Disclosure - Basis of Financial Statement Presentation (USD $)	12 Months Ended
( OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract )
	Dec. 31, 2015



Basis of Financial Statement Presentation	1. BASIS OF FINANCIAL STATEMENTPRESENTATION The accompanying audited financialstatements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. The information furnished in thefinancial statements includes normal recurring adjustments and reflects all adjustments which in the opinion of management arenecessary for a fair presentation of such financial statements.
( us-gaap:BasisOfAccounting )

(End Disclosure - Basis of Financial Statement Presentation)

Disclosure - Organization

Disclosure - Organization (USD $)	12 Months Ended
( OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract )
	Dec. 31, 2015



Organization	2. ORGANIZATION The Company was originally incorporatedunder the name of Big Bear Resources, Inc. a USA Company registered in the State of Nevada on January 23, 2007. TheCompany changed its name to Uranium Plus Resources Inc. on March 21, 2008, and following the acquisition of the assets of ArtVentive,Inc. the Company changed its name on January 26, 2010, to ArtVentive Medical Group, Inc. The accounting and reporting policiesof the Company conform to accounting principles generally accepted in the United States of America, and the Company’s fiscalyear end is December 31. The Company is a medical devicecorporation, focused on developing, manufacturing and marketing a family of Endoluminal Occlusion Devices (EOS™). Throughits innovative, proprietary technology the Company has developed unique minimally invasive occlusion devices and procedures, bringingthe current interventional, image guided techniques to a new level of sophistication, potentially resolving significant and unaddressedhealth issues. The EOS™ device being developed by the Company targets a substantive market demand in several major clinicalareas, including women's health, peripheral and neurological vascular disorders, and interventional cardiology procedures. To date, the Company’s activitieshave been committed to the development of the EOS™, intellectual property, animal studies, human studies, patent filings,and developing a regulatory strategy for initial clinical indications pertinent to European, manufacturing and FDA submissionsand approvals, corporate operations and the raising of equity capital. The Company conducted the required human clinical studiesduring 2011 achieving 100% clinical and procedural success, validating the safety and efficiency of the ArtVentive EOS^TMdevice. The Company received its CE Mark certification for the ArtVentive EOS™ Peripheral device on May 30, 2013. In2014 the Company began commercialization and commenced shipping to its European distributors and preparing the foundation for marketingand sales into the USA markets following regulatory approval. On August 3, 2011, the Company incorporated the ArtVentive Women’s Health Group, Inc., a wholly ownedsubsidiary of the Company and on December 3, 2014 the Company received FDA approval and began to prepare the foundation for itsUSA and global launch.
( us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock )

(End Disclosure - Organization)

Disclosure - Significant Accounting Policies

Disclosure - Significant Accounting Policies (USD $)

12 Months Ended

( AccountingPoliciesAbstract )

Dec. 31, 2015

Significant Accounting Policies

3. SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION

The consolidated financialstatements include the transactions of the Company and its subsidiary.

All inter-company accountsand transactions have been eliminated in consolidation.

USE OF ESTIMATES

The preparation of the Company’sfinancial statements in conformity with accounting principles generally accepted in the United States requires management to makeestimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilitiesat the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Such estimatesinclude deferred tax assets arising as a result of the operating loss carry forwards. Actual results could differ from those estimates.The Company’s periodic filings with the Securities and Exchange Commission include, where applicable, disclosures of estimates,assumptions, uncertainties and markets that could affect the financial statements and future operations of the Company.

COMMON STOCK ISSUED FOR OTHERTHAN CASH

Services purchased and other transactionssettled in the Company’s common stock and stock options are recorded at the estimated fair value of the stock issued andoptions granted if that value is more readily determinable than the fair value of the consideration received.

EARNINGS PER SHARE OF COMMON STOCK

In accordance with accounting guidancenow codified as FASB ASC Topic 260, “Earnings per Share,” basic earnings (loss) per share is computed by dividing netincome (loss) by weighted average number of shares of common stock outstanding during each period.

Diluted earnings (loss) per shareis computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents andpotentially dilutive securities outstanding during the period.

The Company had the following potentialcommon stock equivalents at December 31, 2014:

Common stock warrants 4,200,000

Common stock options 305,000

Total common stock equivalents 4,505,000

Since the Company reflected a netloss in 2014 and 2013, respectively, the effect of considering any common stock equivalents, if outstanding, would have been anti-dilutive.A separate computation of diluted earnings (loss) per share is not presented.

The following table sets forth the computationof earnings per share:

	December 31, 2014	December 31, 2013

Net income (loss)	$ (6,272,967)	$ (3,496,291)

Weighted average common shares outstanding	57,352,546	52,346,677

Net (loss) per share	$ (0.11)	$ (0.07)

PROPERTY AND EQUIPMENT

The Company records property and equipment at cost anduses straight-line depreciation methods.

	Estimated Useful Lives	December 31, 2014	December 31, 2013
Computer equipment Office furniture	5 years 7 years	$ 13,207 4,746	$ 11,634 4,746

Less accumulated depreciation		(5,467)	(2,303)

Net property and equipment		$ 12,486	$ 14,077

INVENTORY

The Company’s inventory is valued at the lower ofcost or market using the first-in, first-out (FIFO) method. As of December 31, 2013 all inventory consisted of raw materials andas of December 31, 2014 all inventory consisted of finished goods.

As the Company begins its transition from the Researchand development phase to production, management has estimated the cost of units sold to be equal to the revenue generated on thoseunits. Other direct costs that may be associated with the production of these units has been reflected in Research and developmentexpenses.

FOREIGN CURRENCY TRANSLATIONS

The Company’s functional andreporting currency is the US dollar. All transactions initiated in other currencies are translated into US dollars using the exchangerate prevailing on the date of transaction.

Monetary assets and liabilitiesdenominated in foreign currencies are translated into the US dollar at the rate of exchange in effect at the balance sheet date.Unrealized exchange gains and losses arising from such transactions are deferred until realization and are included as a separatecomponent of stockholders’ equity (deficit) as a component of other comprehensive income or loss. Upon realization, the amountdeferred is recognized in income in the period when it is realized.

CASH AND CASH EQUIVALENTS

Cash and cash equivalents consistprincipally of funds on hand, on deposit with banks and liquid investment funds having maturity of three months or less at thetime of the purchase. The Company has no cash equivalents. The Company had funds on deposit of $104,030 as of December 31, 2014.

RECEIVABLES

The accounts receivable balanceof $22,662 as of December 31, 2014 is comprised of balances due from two customers; Medicor ($13,212) and Angiocare ($9,450). Therewere no accounts receivable as of December 31, 2013. No bad debts were written off.

REVENUE RECOGNITION

Revenue for the sale of goodsin the course of the ordinary activities is measured at the fair value of the consideration received or receivable, net of returns.Revenue for sale of goods is recognized when the significant risks and rewards of ownership have been transferred to the buyer,recovery of the consideration is probable, the associated costs and possible return of the goods can be estimated reliably, thereis no continuing involvement with the goods, and the amount of revenue can be measured reliably.

CONCENTRATION OF RISK

Certain financial instruments,which subject the Company to concentration of credit risk, consist of cash. The Company maintains cash balances at financial institutions,which, from time to time, may exceed Federal Deposit Insurance Corporation insured limits of $250,000. As of December 31, 2014,the Company had no deposits in excess of federally insured limits in its US bank. The Companyhas not experienced any losses with regard to its bank accounts and believes it is not exposed to any risk of loss on its cashin bank accounts.

( us-gaap:SignificantAccountingPoliciesTextBlock )

(End Disclosure - Significant Accounting Policies)

Disclosure - Note Payable

Disclosure - Note Payable (USD $)

12 Months Ended

( PayablesAndAccrualsAbstract )

Dec. 31, 2015

Note Payable

4. NOTE PAYABLE

On April 1, 2014, the Company borrowed $250,000 froman unrelated party and issued a note payable on or before December 31, 2014, with interest at 3% per annum. On December 31, 2014,the Company and the lender executed an extension of the note, which is now due on or before December 31, 2017. The interest remainsat 3%. The lender may convert all of part of the debt, including interest, into common stock of the Company at any time at therate of $1 per share.

	December 31, 2014	December 31, 2013
Note payable to a private party, with interest at 3.0%, with the balance, interest and principal, due December 31, 2017	$ 250,000	$ -
Note payable to a private party, with interest at 3.0%, with the balance, interest and principal, due December 31, 2017	250,000	-
Total	500,000	-
Less current maturities of long-term debt	-	-
Noncurrent maturities of long-term debt	$ 500,000	$ -

Maturities on long-term debt are as follows:

2015	-
2016	-
2017	$ 500,000
	$ 500,000

( us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock )

(End Disclosure - Note Payable)

Disclosure - Share Capital

Disclosure - Share Capital (USD $)	12 Months Ended
( EquityAbstract )
	Dec. 31, 2015



Share Capital	5. SHARE CAPITAL Effective April 22, 2008, the Companyforward-split its issued common stock on a ratio of 5.8 shares for each original share. As a result of this transaction, 11,078,000shares were issued. Effective February 12, 2010, the Company forward-split its issued common stock on a ratio of 1.65 shares foreach one prior share. As a result of this transaction, 8,442,200 shares were issued. Consideration for the issue ofadditional shares has been charged against additional paid in capital. The forward stock splits adjustments have been applied retroactively. Effective February 7, 2013, 500,000shares were issued in a private placement for the receipt of $500,000. Effective March 5, 2013, 150,000shares were issued in a private placement for the receipt of $150,000. Effective April 22, 2013, 100,000shares were issued in a private placement for the receipt of $100,000. Effective June 4, 2013, 308,000 shareswere issued in a private placement for the receipt of $308,000. Effective July 16, 2013, 300,000shares were issued in a private placement for the receipt of $300,000. Effective August 30, 2013, 200,000shares were issued in a private placement for the receipt of $200,000. Effective September 11, 2013, 200,000shares were issued in a private placement for the receipt of $200,000. Effective September 22, 2013, 300,000shares were issued in a private placement for the receipt of $300,000. Effective October 3, 2013, 300,000shares were issued in a private placement for the receipt of $300,000. Effective October 21, 2013, 400,000shares were issued in a private placement for the receipt of $400,000. Effective November 7, 2013, 400,000shares were issued in a private placement for the receipt of $400,000. Effective November 26, 2013, 400,000shares were issued in a private placement for the receipt of $400,000. Effective December 6, 2013, 400,000shares were issued in a private placement for the receipt of $400,000. Effective December 24, 2013, 400,000shares were issued in a private placement for the receipt of $400,000. Effective January 7, 2014, 400,000shares were issued in a private placement for the receipt of $400,000. Effective February 11, 2014, 400,000 shareswere issued in a private placement for the receipt of $400,000. Effective March 6, 2014, 300,000 shares wereissued in a private placement for the receipt of $300,000. Effective May 23, 2014, 100,000 shares wereissued in a private placement for the receipt of $100,000. Effective June 24, 2014, 1,000,000 shareswere issued in a private placement for the receipt of $1,000,000. Effective July 23, 2014, 500,000 shares wereissued in a private placement for the receipt of $500,000. Effective August 29, 2014, 250,000 shareswere issued in a private placement for the receipt of $250,000. Effective September 29, 2014, 150,000 shareswere issued in a private placement for the receipt of $150,000. Effective September 30, 2014, 100,000 shareswere issued in a private placement for the receipt of $100,000. Effective October 15, 2014, 100,000 shareswere issued in a private placement for the receipt of $100,000 Effective November 7, 2014, 80,000 shareswere issued in a private placement for the receipt of $80,000. Effective November 28, 2014, 70,000 shareswere issued in a private placement for the receipt of $70,000. Effective December 4, 2014, 250,000 shareswere issued in a private placement for the receipt of $250,000. Effective December 15, 2014, 250,000 shareswere issued in a private placement for the receipt of $250,000 Effective December 29, 2014, 250,000 shareswere issued in a private placement for the receipt of $250,000
( us-gaap:StockholdersEquityNoteDisclosureTextBlock )

(End Disclosure - Share Capital)

Disclosure - Going Concern and Liquidity Considerations

Disclosure - Going Concern and Liquidity Considerations (USD $)	12 Months Ended
( OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract )
	Dec. 31, 2015



Going Concern and Liquidity Considerations	6. GOING CONCERN AND LIQUIDITY CONSIDERATIONS The accompanying financial statementshave been prepared assuming that the Company will continue as a going concern, which contemplates, among other things, the realizationof assets and satisfaction of liabilities in the normal course of business. As of December 31, 2014, the Company had a negativeworking capital balance of $1,113,219 and an accumulated deficit of $14,515,214. The Company intends to fund operations throughequity financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirementsfor the next twelve months. The ability of the Company to emergefrom the development stage is dependent upon, among other things, obtaining additional financing to continue operations, research,development and production of its product. In response to these challenges,management intends to raise additional funds through public or private placement offerings. These factors, among others, raisesubstantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do notinclude any adjustments that might result from the outcome of this uncertainty.
( us-gaap:LiquidityDisclosureTextBlock )

(End Disclosure - Going Concern and Liquidity Considerations)

Disclosure - Recently Issued Accounting Pronouncements

Disclosure - Recently Issued Accounting Pronouncements (USD $)	12 Months Ended
( OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract )
	Dec. 31, 2015



Recently Issued Accounting Pronouncements	7.recently issued accounting pronouncements The Company has reviewedAccounting Standards Update (“ASU”) through ASU No. 2014-18 which contain technical corrections to existing guidanceor affect guidance to specialized industries or entities. These updates have no current applicability to the Company or their effecton the financial statements would not have been significant.
( us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock )

(End Disclosure - Recently Issued Accounting Pronouncements)

Disclosure - Provisions for Income Taxes

Disclosure - Provisions for Income Taxes (USD $)

12 Months Ended

( IncomeTaxDisclosureAbstract )

Dec. 31, 2015

Provisions for Income Taxes

8. provisionfor income taxes

The Company recognizes the taxeffects of transactions in the year in which such transactions enter into the determination of net income, regardless of when reportedfor tax purposes. Deferred taxes are provided in the financial statements under ASC Topic 740 to give effect to the resulting temporarydifferences which may arise from differences in the bases of fixed assets, depreciation methods, allowances, and start-up costsbased on the income taxes expected to be payable in future years. Exploration and development stage deferred tax assets arisingas a result of net operating loss carryforwards have been offset completely by a valuation allowance due to the uncertainty oftheir utilization in future periods. Tax operating loss carryforwards generated during the period from January 23, 2007 (date ofinception) through December 31, 2014 of approximately $14,492,206 will begin to expire in 2027. Accordingly, deferred tax assetsof approximately $6,074,247 (2013 – $3,407,430) related to net operating loss carry-forwards and $99,915 related to stock-basedcompensation were offset by the valuation allowance in the same amount.

The Company adopted the provisionsof FASB Interpretation No. 48 Accounting for Uncertainty in Income Taxes, on January 23, 2007. As a result of the implementationof Interpretation 48, the Company recognized no increase in the liability for unrecognized tax benefits.

The Company has no tax positionsat December 31, 2014 and 2013 for which the ultimate deductibility is highly certain but for which there is uncertainty about thetiming of such deductibility.

The Company’s tax returnsfor the years ended December 31, 2014, 2013, 2012 and 2011 are open for examination under Federal Statute of Limitations and forthe years ended December 31, 2014, 2013 and 2012 under the State of California Statute of Limitations.

The Company recognizes interestaccrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company had no accrualsfor interest and penalties since inception.

Components of income tax benefitsare as follows:

	Years Ended December 31,
	2014	2013
Current	$ -	$ -
Federal	-	-
State	-	-
Deferred	-	-
	$ -	$ -

A reconciliation of the provision for income tax expensewith the expected income tax computed by applying the federal statutory income tax to income before provision for income taxesis as follows:

	Years Ended December 31
	2014	2013
Income tax (benefit) computed at
Federal statutory tax rate of 34%	$ (2,132,809)	$ (1,188,739)
Change in valuation allowance	2,687,339	1,497,811
State taxes (net of federal benefit)	(554,530)	(309,072)
	$ -	$ -

( us-gaap:IncomeTaxDisclosureTextBlock )

(End Disclosure - Provisions for Income Taxes)

Disclosure - Warrants and Options

Disclosure - Warrants and Options (USD $)

12 Months Ended

( EquityAbstract )

Dec. 31, 2015

Warrants and Options

9. WARRANTSAND OPTIONS

During the fiscal year ended December31, 2014, the Company granted 4,200,000 warrants to purchase shares of Common Stock which all have a 1 year exercise term. TheCompany valued these warrants utilizing a Black-Scholes option pricing model and the fair value was recorded in additional paid-incapital.

The following is a summary of theCompany’s warrant activity:


	Warrants	Weighted Average Exercise Price
Granted-2013	4,358,000	$ 1.50
Exercised-2013	-	-
Forfeited-2013	(1,500,000)	$ 1.50
Outstanding – December 31, 2013	4,358,000	$ 1.50
Exercisable – December 31, 2013	4,358,000	$ 1.50

	Warrants	Weighted Average Exercise Price
Granted-2014	4,200,000	$ 1.50
Exercised-2014	-	-
Forfeited-2014	(4,358,000)	$ 1.50
Outstanding – December 31, 2014	4,200,000	$ 1.50
Exercisable – December 31, 2014	4,200,000	$ 1.50

Warrants outstanding and exercisableat December 31, 2014 are as follows:

Warrants Outstanding				Warrants Exercisable
	Range of Exercise Price	Number Outstanding	Weighted Average Remaining Contractual Life (in Years)	Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	1.50	400,000	0.01 years	$	1.50		400,000		$	1.50
$	1.50	400,000	0.10 years	$	1.50		400,000		$	1.50
$	1.50	300,000	0.18 years	$	1.50		300,000		$	1.50
$	1.50	100,000	0.39 years	$	1.50		100,000		$	1.50
$	1.50	1,000,000	0.48 years	$	1.50		1,000,000		$	1.50
$	1.50	500,000	0.55 years	$	1.50		500,000		$	1.50
$	1.50	250,000	0.65 years	$	1.50		250,000		$	1.50
$	1.50	150,000	0.71 years	$	1.50		150,000		$	1.50
$	1.50	100,000	0.75 years	$	1.50		100,000		$	1.50
$	1.50	100,000	0.79 years	$	1.50		100,000		$	1.50
$$	1.50	80,000	0.85 years	$	1.50		80,000		$	1.50
$	1.50	70,000	0.91 years	$	1.50		70,000		$	1.50
$	1.50	250,000	0.92 years	$	1.50		250,000		$	1.50
$	1.50	250,000	0.96 years	$	1.50		250,000		$	1.50
$	1.50	250.000	1.00 years	$	1.50		250,000		$	1.50

Stock option activity is as follows:

Effective November 2, 2010, the Boardof Directors of the Company granted 50,000 non-statutory stock options to a former consultant at an exercise price of $.001 pershare with the vesting date of November 2, 2013 and an expiration date of November 2, 2016.

Effective February 1, 2013, theBoard of Directors of the Company granted 20,000 non-statutory stock options to a current consultant at an exercise price of $1.00per share with the vesting date of February 1, 2013 and an expiration date of February 1, 2018.

Effective February 1, 2013, theBoard of Directors of the Company granted 5,000 non-statutory stock options to a current consultant at an exercise price of $1.00per share with the vesting date of February 1 2013 and an expiration date of February 1, 2018.

Effective February 1, 2013, theBoard of Directors of the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00per share with the vesting date of February 1 2013 and an expiration date of February 1, 2018.

Effective March 1, 2013, the Boardof Directors of the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00 pershare with the vesting date of March 1, 2013 and an expiration date of March 1, 2018.

Effective December 1, 2013, the Board of Directorsgranted 200,000 stock options deemed an Incentive Stock Option (ISO) to a current employee, at an exercise price of $1.00 per sharewith 25% exercisable on January 1, 2014; and an additional 25% exercisable on each of the next succeeding three anniversaries ofDecember 1, on a cumulative basis, so that the Option, or any unexercised portion, shall be fully exercisable on and after December1, 2017. The stock options have an expiration date of November 30, 2023.

Effective December 27, 2013, theBoard of Directors of the Company granted 10,000 non-statutory stock options to a current consultant at an exercise price of $1.00per share with the vesting date of December 27, 2013, and an expiration date of December 27, 2018.

During the period that the optionswere issued, the Company had no public trading activity for the Company’s common stock. However, the majority shareholdersold in private transactions shares at $.90 per share. In order to value the Company’s options, the Company chose to usethe minimum value method, even though the Company is a public company since there was no measurable trading activity. The fairvalue of the options was recorded in additional paid-in capital.

Warrant activity isas follows:

Warrants issued during 2013, totaling4,358,000, expired during 2014.

Effective January 7, 2014, 400,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year.

Effective February 11, 2014, 400,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year.

Effective March 6, 2014, 300,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year.

Effective May 23, 2014, 100,000 warrants were issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and thewarrants expire in 1 year.

Effective June 24, 2014, 1,000,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year.

Effective July 23, 2014, 500,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period, and thewarrants expire in 1 year

Effective August 29, 2014, 250,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year

Effective September 29, 2014, 150,000 warrantswere issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year

Effective September 30, 2014, 100,000 warrantswere issued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year

Effective October 15, 2014, 100,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year

Effective November 7, 2014, 80,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year

Effective November 28, 2014, 70,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year

Effective December 4, 2014, 250,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year

Effective December 15, 2014, 250,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year.

Effective December 31, 2014, 250,000 warrants wereissued. The warrants allow the purchase of common shares at an exercise price of $1.50. There is no vesting period,and the warrants expire in 1 year.

Options outstanding and exercisableat December 31, 2014 are as follows:

	Options	Weighted Average Exercise Price
Granted-2013	255,000	$ 1.00
Exercised-2013	-	-
Forfeited-2013	-	$ -
Outstanding – December 31, 2013	305,000	$ 0.836
Exercisable – December 31, 2013	305,000	$ 0.836
	Options	Weighted Average Exercise Price
Granted-2014	-	$ -
Exercised-2014	-	-
Forfeited-2014	-	-
Outstanding – December 31, 2014	305,000	$ 0.836
Exercisable – December 31, 2014	305,000	$ 0.836

Options outstandingand exercisable at December 31, 2014 are as follows:

Options Outstanding							Options Exercisable
	Range of Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$		0.001		50,000		1.84 years	$	0.001		50,000		$	0.001
$		1.000		35,000		3.09 years	$	1.000		35,000		$	1.000
$		1.000		10,000		3.16 years	$	1.000		10,000		$	1.000
$		1.000		10,000		3.99 years	$	1.000		-		$	1.000
$		1.000		200,000		8.92 years	$	1.000		10,000		$	1.000

( us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock )

(End Disclosure - Warrants and Options)

Disclosure - Subsequent Events

Disclosure - Subsequent Events (USD $)	12 Months Ended
( SubsequentEventsAbstract )
	Dec. 31, 2015



Subsequent Events	10. subsequentevents The Company evaluated all events or transactions that occurredafter December 31, 2014, up through the date these consolidated financial statements were issued. Effective January 1, 2015, the Board of Directors granted50,000 stock options deemed an Incentive Stock Option (ISO) to a current employee, at an exercise price of $1.00 per share with25% exercisable on January 1, 2016; and an additional 25% exercisable on each of the next succeeding three anniversaries of January1, on a cumulative basis, so that the Option, or any unexercised portion, shall be fully exercisable on and after January 1, 2019.The stock options have an expiration date of January 1, 2025. Effective January 5, 2015, the Companyissued 250,000 shares in a private placement for a receipt of $300,000 Effective January 23, 2015, the Companyissued 250,000 shares in a private placement for a receipt of $300,000
( us-gaap:SubsequentEventsTextBlock )

(End Disclosure - Subsequent Events)

Disclosure - Significant Accounting Policies (Policies)

Disclosure - Significant Accounting Policies (Policies) (USD $)

12 Months Ended

( AccountingPoliciesAbstract )

Dec. 31, 2015

Principles of Consolidation

PRINCIPLES OF CONSOLIDATION

The consolidated financialstatements include the transactions of the Company and its subsidiary.

All inter-company accountsand transactions have been eliminated in consolidation.

( us-gaap:ConsolidationPolicyTextBlock )

USE OF ESTIMATES

USE OF ESTIMATES

( us-gaap:UseOfEstimates )

COMMON STOCK ISSUED FOR OTHER THAN CASH

COMMON STOCK ISSUED FOR OTHERTHAN CASH

( us-gaap:CompensationRelatedCostsPolicyTextBlock )

EARNINGS PER SHARE OF COMMON STOCK

EARNINGS PER SHARE OF COMMON STOCK

The Company had the following potentialcommon stock equivalents at December 31, 2014:

Common stock warrants 4,200,000

Common stock options 305,000

Total common stock equivalents 4,505,000

The following table sets forth the computationof earnings per share:

	December 31, 2014	December 31, 2013

Net income (loss)	$ (6,272,967)	$ (3,496,291)

Weighted average common shares outstanding	57,352,546	52,346,677

Net (loss) per share	$ (0.11)	$ (0.07)

( us-gaap:EarningsPerSharePolicyTextBlock )

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT

The Company records property and equipment at cost anduses straight-line depreciation methods.

	Estimated Useful Lives	December 31, 2014	December 31, 2013
Computer equipment Office furniture	5 years 7 years	$ 13,207 4,746	$ 11,634 4,746

Less accumulated depreciation		(5,467)	(2,303)

Net property and equipment		$ 12,486	$ 14,077

( us-gaap:PropertyPlantAndEquipmentPolicyTextBlock )

INVENTORY

INVENTORY

( us-gaap:InventoryPolicyTextBlock )

FOREIGN CURRENCY TRANSLATIONS

FOREIGN CURRENCY TRANSLATIONS

( us-gaap:ForeignCurrencyDisclosureTextBlock )

CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS

( us-gaap:CashAndCashEquivalentsPolicyTextBlock )

RECEIVABLES

RECEIVABLES

( us-gaap:ReceivablesPolicyTextBlock )

REVENUE RECOGNITION

REVENUE RECOGNITION

( us-gaap:RevenueRecognitionPolicyTextBlock )

CONCENTRATION OF RISK

CONCENTRATION OF RISK

( us-gaap:ConcentrationRiskCreditRisk )

(End Disclosure - Significant Accounting Policies (Policies))

Disclosure - Significant Accounting Policies (Tables)

Disclosure - Significant Accounting Policies (Tables) (USD $)

12 Months Ended

( AccountingPoliciesAbstract )

Dec. 31, 2015

Computation of Earnings Per Share

	December 31, 2014	December 31, 2013

Net income (loss)	$ (6,272,967)	$ (3,496,291)

Weighted average common shares outstanding	57,352,546	52,346,677

Net (loss) per share	$ (0.11)	$ (0.07)

( us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock )

(End Disclosure - Significant Accounting Policies (Tables))

Disclosure - Note Payable (Tables)

Disclosure - Note Payable (Tables) (USD $)

12 Months Ended

( PayablesAndAccrualsAbstract )

Dec. 31, 2015

Notes Payable

	December 31, 2014	December 31, 2013
Note payable to a private party, with interest at 3.0%, with the balance, interest and principal, due December 31, 2017	$ 250,000	$ -
Note payable to a private party, with interest at 3.0%, with the balance, interest and principal, due December 31, 2017	250,000	-
Total	500,000	-
Less current maturities of long-term debt	-	-
Noncurrent maturities of long-term debt	$ 500,000	$ -

( us-gaap:ScheduleOfDebtInstrumentsTextBlock )

(End Disclosure - Note Payable (Tables))

Disclosure - Provisions for Income Taxes (Tables)

Disclosure - Provisions for Income Taxes (Tables) (USD $)

12 Months Ended

( IncomeTaxDisclosureAbstract )

Dec. 31, 2015

Components of Income Tax Benefits

	Years Ended December 31,
	2014	2013
Current	$ -	$ -
Federal	-	-
State	-	-
Deferred	-	-
	$ -	$ -

( us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock )

Reconciliation of Income Tax

	Years Ended December 31
	2014	2013
Income tax (benefit) computed at
Federal statutory tax rate of 34%	$ (2,132,809)	$ (1,188,739)
Change in valuation allowance	2,687,339	1,497,811
State taxes (net of federal benefit)	(554,530)	(309,072)
	$ -	$ -

( us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock )

(End Disclosure - Provisions for Income Taxes (Tables))

Disclosure - Warrants and Options (Tables)

Disclosure - Warrants and Options (Tables) (USD $)

12 Months Ended

( EquityAbstract )

Dec. 31, 2015

Warrant Activities


	Warrants	Weighted Average Exercise Price
Granted-2013	4,358,000	$ 1.50
Exercised-2013	-	-
Forfeited-2013	(1,500,000)	$ 1.50
Outstanding – December 31, 2013	4,358,000	$ 1.50
Exercisable – December 31, 2013	4,358,000	$ 1.50

	Warrants	Weighted Average Exercise Price
Granted-2014	4,200,000	$ 1.50
Exercised-2014	-	-
Forfeited-2014	(4,358,000)	$ 1.50
Outstanding – December 31, 2014	4,200,000	$ 1.50
Exercisable – December 31, 2014	4,200,000	$ 1.50

Warrants outstanding and exercisableat December 31, 2014 are as follows:

Warrants Outstanding				Warrants Exercisable
	Range of Exercise Price	Number Outstanding	Weighted Average Remaining Contractual Life (in Years)	Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	1.50	400,000	0.01 years	$	1.50		400,000		$	1.50
$	1.50	400,000	0.10 years	$	1.50		400,000		$	1.50
$	1.50	300,000	0.18 years	$	1.50		300,000		$	1.50
$	1.50	100,000	0.39 years	$	1.50		100,000		$	1.50
$	1.50	1,000,000	0.48 years	$	1.50		1,000,000		$	1.50
$	1.50	500,000	0.55 years	$	1.50		500,000		$	1.50
$	1.50	250,000	0.65 years	$	1.50		250,000		$	1.50
$	1.50	150,000	0.71 years	$	1.50		150,000		$	1.50
$	1.50	100,000	0.75 years	$	1.50		100,000		$	1.50
$	1.50	100,000	0.79 years	$	1.50		100,000		$	1.50
$$	1.50	80,000	0.85 years	$	1.50		80,000		$	1.50
$	1.50	70,000	0.91 years	$	1.50		70,000		$	1.50
$	1.50	250,000	0.92 years	$	1.50		250,000		$	1.50
$	1.50	250,000	0.96 years	$	1.50		250,000		$	1.50
$	1.50	250.000	1.00 years	$	1.50		250,000		$	1.50

( us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock )

Options Activity

	Options	Weighted Average Exercise Price
Granted-2013	255,000	$ 1.00
Exercised-2013	-	-
Forfeited-2013	-	$ -
Outstanding – December 31, 2013	305,000	$ 0.836
Exercisable – December 31, 2013	305,000	$ 0.836
	Options	Weighted Average Exercise Price
Granted-2014	-	$ -
Exercised-2014	-	-
Forfeited-2014	-	-
Outstanding – December 31, 2014	305,000	$ 0.836
Exercisable – December 31, 2014	305,000	$ 0.836

Options outstandingand exercisable at December 31, 2014 are as follows:

Options Outstanding							Options Exercisable
	Range of Exercise Price		Number Outstanding		Weighted Average Remaining Contractual Life (in Years)		Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$		0.001		50,000		1.84 years	$	0.001		50,000		$	0.001
$		1.000		35,000		3.09 years	$	1.000		35,000		$	1.000
$		1.000		10,000		3.16 years	$	1.000		10,000		$	1.000
$		1.000		10,000		3.99 years	$	1.000		-		$	1.000
$		1.000		200,000		8.92 years	$	1.000		10,000		$	1.000

( us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock )

(End Disclosure - Warrants and Options (Tables))

Disclosure - Significant Accounting Policies - Computation of Earnings Per Share (Details)

Disclosure - Significant Accounting Policies - Computation of Earnings Per Share (Details) (USD $)	12 Months Ended
( AccountingPoliciesAbstract )
	Dec. 31, 2014		Dec. 31, 2013





Net income (loss)	(6,272,967	)	(3,496,291	)
( us-gaap:IncomeLossFromContinuingOperations )


Weighted average common shares outstanding	57,352,546		52,346,677
( us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted )


Net (loss) per share	(0.11	)	(0.07	)
( us-gaap:IncomeLossFromOperationsBeforeExtraordinaryItemsPerBasicAndDilutedShare )

(End Disclosure - Significant Accounting Policies - Computation of Earnings Per Share (Details))

Disclosure - Significant Accounting Policies (Details Narrative)

Disclosure - Significant Accounting Policies (Details Narrative) (USD $)
( AccountingPoliciesAbstract )




Funds on Deposit	$104,030
( us-gaap:CustomerAdvancesAndDeposits )
Accounts Receivable	$22,662
( us-gaap:AccountsReceivableGross )

(End Disclosure - Significant Accounting Policies (Details Narrative))

Disclosure - Subsequent Events (Details Narrative)

Disclosure - Subsequent Events (Details Narrative) (USD $)
( SubsequentEventsAbstract )




Private Placement	$300,000
( us-gaap:ProceedsFromIssuanceOfPrivatePlacement )

(End Disclosure - Subsequent Events (Details Narrative))

Contexts

ID	Period	CIK	Dimensions
From2015-01-01to2015-12-31	2015-01-01 - 2015-12-31	0001405249
AsOf2014-06-30	2014-06-30	0001405249
AsOf2015-03-27	2015-03-27	0001405249
AsOf2014-12-31	2014-12-31	0001405249
AsOf2013-12-31	2013-12-31	0001405249
From2014-01-01to2014-12-31	2014-01-01 - 2014-12-31	0001405249
From2013-01-01to2013-12-31	2013-01-01 - 2013-12-31	0001405249
AsOf2012-12-31	2012-12-31	0001405249
From2012-01-01to2012-12-31_us-gaap_CommonStockMember	2012-01-01 - 2012-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:CommonStockMember
From2013-01-01to2013-12-31_us-gaap_CommonStockMember	2013-01-01 - 2013-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:CommonStockMember
From2014-01-01to2014-12-31_us-gaap_CommonStockMember	2014-01-01 - 2014-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:CommonStockMember
AsOf2011-12-31_us-gaap_CommonStockMember	2011-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:CommonStockMember
AsOf2012-12-31_us-gaap_CommonStockMember	2012-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:CommonStockMember
AsOf2013-12-31_us-gaap_CommonStockMember	2013-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:CommonStockMember
AsOf2014-12-31_us-gaap_CommonStockMember	2014-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:CommonStockMember
From2012-01-01to2012-12-31_us-gaap_AdditionalPaidInCapitalMember	2012-01-01 - 2012-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AdditionalPaidInCapitalMember
From2013-01-01to2013-12-31_us-gaap_AdditionalPaidInCapitalMember	2013-01-01 - 2013-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AdditionalPaidInCapitalMember
From2014-01-01to2014-12-31_us-gaap_AdditionalPaidInCapitalMember	2014-01-01 - 2014-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AdditionalPaidInCapitalMember
AsOf2011-12-31_us-gaap_AdditionalPaidInCapitalMember	2011-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AdditionalPaidInCapitalMember
AsOf2012-12-31_us-gaap_AdditionalPaidInCapitalMember	2012-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AdditionalPaidInCapitalMember
AsOf2013-12-31_us-gaap_AdditionalPaidInCapitalMember	2013-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AdditionalPaidInCapitalMember
AsOf2014-12-31_us-gaap_AdditionalPaidInCapitalMember	2014-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AdditionalPaidInCapitalMember
From2012-01-01to2012-12-31_us-gaap_RetainedEarningsMember	2012-01-01 - 2012-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:RetainedEarningsMember
From2013-01-01to2013-12-31_us-gaap_RetainedEarningsMember	2013-01-01 - 2013-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:RetainedEarningsMember
From2014-01-01to2014-12-31_us-gaap_RetainedEarningsMember	2014-01-01 - 2014-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:RetainedEarningsMember
AsOf2011-12-31_us-gaap_RetainedEarningsMember	2011-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:RetainedEarningsMember
AsOf2012-12-31_us-gaap_RetainedEarningsMember	2012-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:RetainedEarningsMember
AsOf2013-12-31_us-gaap_RetainedEarningsMember	2013-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:RetainedEarningsMember
AsOf2014-12-31_us-gaap_RetainedEarningsMember	2014-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:RetainedEarningsMember
From2012-01-01to2012-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember	2012-01-01 - 2012-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AccumulatedOtherComprehensiveIncomeMember
From2013-01-01to2013-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember	2013-01-01 - 2013-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AccumulatedOtherComprehensiveIncomeMember
From2014-01-01to2014-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember	2014-01-01 - 2014-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AccumulatedOtherComprehensiveIncomeMember
AsOf2011-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember	2011-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AccumulatedOtherComprehensiveIncomeMember
AsOf2012-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember	2012-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AccumulatedOtherComprehensiveIncomeMember
AsOf2013-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember	2013-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AccumulatedOtherComprehensiveIncomeMember
AsOf2014-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember	2014-12-31	0001405249	us-gaap:StatementEquityComponentsAxis: us-gaap:AccumulatedOtherComprehensiveIncomeMember
From2012-01-01to2012-12-31	2012-01-01 - 2012-12-31	0001405249
AsOf2011-12-31	2011-12-31	0001405249

(End Contexts)

Elements

Element		Data Type

AccountingPoliciesAbstract		xbrli:stringItemType	Duration	—

EquityAbstract		xbrli:stringItemType	Duration	—

IncomeTaxDisclosureAbstract		xbrli:stringItemType	Duration	—

OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract		xbrli:stringItemType	Duration	—

PayablesAndAccrualsAbstract		xbrli:stringItemType	Duration	—

SubsequentEventsAbstract		xbrli:stringItemType	Duration	—

custom:DocumentAndEntityInformationAbstract		xbrli:stringItemType	Duration	—	Yes (Auto)

dei:AmendmentFlag		xbrli:booleanItemType	Duration	—
	If the value is true, then the document is an amendment to previously-filed/accepted document.
dei:CurrentFiscalYearEndDate		xbrli:gMonthDayItemType	Duration	—
	End date of current fiscal year in the format --MM-DD.
dei:DocumentFiscalPeriodFocus		dei:fiscalPeriodItemType	Duration	—
	This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
dei:DocumentFiscalYearFocus		xbrli:gYearItemType	Duration	—
	This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
dei:DocumentPeriodEndDate		xbrli:dateItemType	Duration	—
	The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
dei:DocumentType		dei:submissionTypeItemType	Duration	—
	The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
dei:EntityCentralIndexKey		dei:centralIndexKeyItemType	Duration	—
	A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
dei:EntityCommonStockSharesOutstanding		xbrli:sharesItemType	Instant	—
	Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
dei:EntityCurrentReportingStatus		dei:yesNoItemType	Duration	—
	Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
dei:EntityFilerCategory		dei:filerCategoryItemType	Duration	—
	Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
dei:EntityPublicFloat		xbrli:monetaryItemType	Instant	Credit
	State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.
dei:EntityRegistrantName		xbrli:normalizedStringItemType	Duration	—
	The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
dei:EntityVoluntaryFilers		dei:yesNoItemType	Duration	—
	Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
dei:EntityWellKnownSeasonedIssuer		dei:yesNoItemType	Duration	—
	Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock		nonnum:textBlockItemType	Duration	—
	The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.
us-gaap:AccountsPayableCurrent		xbrli:monetaryItemType	Instant	Credit
	Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
us-gaap:AccountsReceivableGross		xbrli:monetaryItemType	Instant	Debit
	For unclassified balance sheet, amounts due from customers or clients for goods or services that have been delivered or sold in the normal course of business.
us-gaap:AccountsReceivableNet		xbrli:monetaryItemType	Instant	Debit
	For an unclassified balance sheet, the amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business, reduced to their estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
us-gaap:AccruedLiabilitiesCurrent		xbrli:monetaryItemType	Instant	Credit
	Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
us-gaap:AccruedLiabilitiesCurrentAndNoncurrent		xbrli:monetaryItemType	Instant	Credit
	Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.
us-gaap:AccruedPayrollTaxesCurrent		xbrli:monetaryItemType	Instant	Credit
	Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment		xbrli:monetaryItemType	Instant	Credit
	Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
us-gaap:AccumulatedOtherComprehensiveIncomeMember		nonnum:domainItemType	Duration	—
	Accumulated change in equity from transactions and other events and circumstances from non-owner sources at fiscal year-end. Excludes Net Income or Loss, and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, and unrealized gains and losses on certain investments in debt and equity securities as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
us-gaap:AdditionalPaidInCapital		xbrli:monetaryItemType	Instant	Credit
	Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
us-gaap:AdditionalPaidInCapitalMember		nonnum:domainItemType	Duration	—
	Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.
us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities		xbrli:monetaryItemType	Duration	Debit
	The aggregate amount of adjustments to net income or loss necessary to remove the effects of all items whose cash effects are investing or financing cash flows. The aggregate amount also includes all noncash expenses and income items which reduce or increase net income and are thus added back or deducted when calculating cash provided by or used in operating activities.
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature		xbrli:monetaryItemType	Duration	Credit
	Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.
us-gaap:AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract		xbrli:stringItemType	Duration	—

us-gaap:Assets		xbrli:monetaryItemType	Instant	Debit
	Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
us-gaap:AssetsCurrent		xbrli:monetaryItemType	Instant	Debit
	Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
us-gaap:AssetsCurrentAbstract		xbrli:stringItemType	Duration	—

us-gaap:BasisOfAccounting		nonnum:textBlockItemType	Duration	—
	The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
us-gaap:Cash		xbrli:monetaryItemType	Instant	Debit
	Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.
us-gaap:CashAndCashEquivalentsAtCarryingValue		xbrli:monetaryItemType	Instant	Debit
	Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease		xbrli:monetaryItemType	Duration	Debit
	Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
us-gaap:CashAndCashEquivalentsPolicyTextBlock		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
us-gaap:CommonStockMember		nonnum:domainItemType	Duration	—
	Stock that is subordinate to all other stock of the issuer.
us-gaap:CommonStockParOrStatedValuePerShare		num:perShareItemType	Instant	—
	Face amount or stated value per share of common stock.
us-gaap:CommonStockSharesAuthorized		xbrli:sharesItemType	Instant	—
	The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
us-gaap:CommonStockSharesIssued		xbrli:sharesItemType	Instant	—
	Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
us-gaap:CompensationRelatedCostsPolicyTextBlock		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.
us-gaap:ComprehensiveIncomeNetOfTax		xbrli:monetaryItemType	Duration	Credit
	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
us-gaap:ConcentrationRiskCreditRisk		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy for credit risk.
us-gaap:ConsolidationPolicyTextBlock		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.
us-gaap:CostOfGoodsSold		xbrli:monetaryItemType	Duration	Debit
	Total costs related to goods produced and sold during the reporting period.
us-gaap:CustomerAdvancesAndDeposits		xbrli:monetaryItemType	Instant	Credit
	Refundable consideration, usually cash, held by the entity pending satisfactory completion of the entity's obligations or pending the closing of a contract.
us-gaap:Deposits		xbrli:monetaryItemType	Instant	Credit
	The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.
us-gaap:Depreciation		xbrli:monetaryItemType	Duration	Debit
	The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
us-gaap:DepreciationAndAmortization		xbrli:monetaryItemType	Duration	Debit
	The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage		xbrli:monetaryItemType	Instant	Debit
	Cumulative net losses reported during the development stage.
us-gaap:EarningsPerSharePolicyTextBlock		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
us-gaap:EmployeeBenefitsAndShareBasedCompensation		xbrli:monetaryItemType	Duration	Debit
	Costs and payments related to employee benefits and equity-based compensation, such as pension expense and contributions, other postretirement benefits expense and payments, stock or unit options expense, and amortization of restricted stock or unit.
us-gaap:EquityComponentDomain		nonnum:domainItemType	Duration	—
	Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.
us-gaap:ExplorationCosts		xbrli:monetaryItemType	Duration	Debit
	The capitalized costs incurred during the period (excluded from amortization) in identifying areas that may warrant examination and in examining specific areas that are considered to have prospects of containing oil and gas reserves, including costs of drilling exploratory wells and exploratory-type stratigraphic test wells. Exploration costs may be incurred both before acquiring the related property (sometimes referred to in part as prospecting costs) and after acquiring the property. Principal types of exploration costs, which include depreciation and applicable operating costs of support equipment and facilities and other costs of exploration activities, are: costs of topographical, geographical and geophysical studies, rights of access to properties to conduct those studies, and salaries and other expenses of geologists, geophysical crews, and others conducting those studies. Collectively, these are sometimes referred to as geological and geophysical or "G&G" costs. Exploration costs also include costs o
us-gaap:ForeignCurrencyDisclosureTextBlock		nonnum:textBlockItemType	Duration	—
	The entire disclosure for foreign currency transactions and translation. This may include description of foreign currency transactions, foreign currency gains and losses, explanation of change in cumulative translation adjustment, description of effect of subsequent foreign currency exchange rate change, cumulative translation adjustment movement, foreign currency translation adjustment by component movement, translation adjustment for net investment hedge movement, adjustment for long-term intercompany transactions, schedule of long-term intercompany balances and any other foreign currency transactions and translation related items.
us-gaap:GrossProfit		xbrli:monetaryItemType	Duration	Credit
	Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
us-gaap:IncomeLossFromContinuingOperations		xbrli:monetaryItemType	Duration	Credit
	Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic		xbrli:monetaryItemType	Duration	Credit
	The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.
us-gaap:IncomeLossFromContinuingOperationsPerBasicAndDilutedShare		num:perShareItemType	Duration	—
	The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.
us-gaap:IncomeLossFromOperationsBeforeExtraordinaryItemsPerBasicAndDilutedShare		num:perShareItemType	Duration	—
	The amount of net income (loss) before extraordinary items per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares.
us-gaap:IncomeStatementAbstract		xbrli:stringItemType	Duration	—

us-gaap:IncomeTaxDisclosureTextBlock		nonnum:textBlockItemType	Duration	—
	The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
us-gaap:IncomeTaxesPaid		xbrli:monetaryItemType	Duration	Credit
	The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.
us-gaap:IncomeTaxesPaidNet		xbrli:monetaryItemType	Duration	Credit
	The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
us-gaap:IncreaseDecreaseInAccountsPayable		xbrli:monetaryItemType	Duration	Debit
	The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
us-gaap:IncreaseDecreaseInAccountsReceivable		xbrli:monetaryItemType	Duration	Credit
	The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
us-gaap:IncreaseDecreaseInAccruedLiabilities		xbrli:monetaryItemType	Duration	Debit
	The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
us-gaap:IncreaseDecreaseInDeposits		xbrli:monetaryItemType	Duration	Debit
	The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances.
us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities		xbrli:monetaryItemType	Duration	Debit
	The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
us-gaap:IncreaseDecreaseInInventories		xbrli:monetaryItemType	Duration	Credit
	The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
us-gaap:IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract		xbrli:stringItemType	Duration	—

us-gaap:IncreaseDecreaseInPrepaidExpense		xbrli:monetaryItemType	Duration	Credit
	The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.
us-gaap:InterestAndDividendIncomeOperating		xbrli:monetaryItemType	Duration	Credit
	Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.
us-gaap:InterestPaid		xbrli:monetaryItemType	Duration	Credit
	The amount of cash paid for interest during the period.
us-gaap:InventoryGross		xbrli:monetaryItemType	Instant	Debit
	Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
us-gaap:InventoryPolicyTextBlock		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory.
us-gaap:LiabilitiesAndStockholdersEquity		xbrli:monetaryItemType	Instant	Credit
	Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
us-gaap:LiabilitiesAndStockholdersEquityAbstract		xbrli:stringItemType	Duration	—

us-gaap:LiabilitiesCurrent		xbrli:monetaryItemType	Instant	Credit
	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
us-gaap:LiabilitiesCurrentAbstract		xbrli:stringItemType	Duration	—

us-gaap:LiquidityDisclosureTextBlock		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy for reporting when there is a substantial doubt about an entity's ability to continue as a going concern for a reasonable period of time (generally a year from the balance sheet date). Disclose: (a) pertinent conditions and events giving rise to the assessment of substantial doubt about the entity's ability to continue as a going concern for a reasonable period of time, (b) the possible effects of such conditions and events, (c) management's evaluation of the significance of those conditions and events and any mitigating factors, (d) possible discontinuance of operations, (e) management's plans (including relevant prospective financial information), and (f) information about the recoverability or classification of recorded asset amounts or the amounts or classification of liabilities. If management's plans alleviate the substantial doubt about the entity's ability to continue as a going concern, disclosure of the principal conditions and events that initially raised the substa
us-gaap:LongTermDebtAbstract		xbrli:stringItemType	Duration	—

us-gaap:LongTermDebtNoncurrent		xbrli:monetaryItemType	Instant	Credit
	Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
us-gaap:NetCashProvidedByUsedInContinuingOperations		xbrli:monetaryItemType	Duration	—
	The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.
us-gaap:NetCashProvidedByUsedInFinancingActivities		xbrli:monetaryItemType	Duration	Debit
	Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
us-gaap:NetCashProvidedByUsedInFinancingActivitiesAbstract		xbrli:stringItemType	Duration	—

us-gaap:NetCashProvidedByUsedInInvestingActivities		xbrli:monetaryItemType	Duration	Debit
	Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
us-gaap:NetCashProvidedByUsedInInvestingActivitiesAbstract		xbrli:stringItemType	Duration	—

us-gaap:NetCashProvidedByUsedInOperatingActivitiesAbstract		xbrli:stringItemType	Duration	—

us-gaap:NetIncomeLoss		xbrli:monetaryItemType	Duration	Credit
	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic		xbrli:monetaryItemType	Duration	Credit
	Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted		xbrli:monetaryItemType	Duration	Credit
	Net Income or Loss Available to Common Stockholders plus adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.
us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
us-gaap:NotesPayable		xbrli:monetaryItemType	Instant	Credit
	Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.
us-gaap:OperatingExpensesAbstract		xbrli:stringItemType	Duration	—

us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock		nonnum:textBlockItemType	Duration	—
	The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.
us-gaap:OtherAssets		xbrli:monetaryItemType	Instant	Debit
	The aggregate carrying amounts, as of the balance sheet date, of assets not separately disclosed in the balance sheet.
us-gaap:OtherAssetsAbstract		xbrli:stringItemType	Duration	—

us-gaap:OtherIncomeAndExpensesAbstract		xbrli:stringItemType	Duration	—

us-gaap:OtherNoncashIncomeExpense		xbrli:monetaryItemType	Duration	Credit
	Other income (expense) included in net income that results in no cash inflows or outflows in the period. Includes noncash adjustments to reconcile net income (loss) to cash provided by (used in) operating activities that are not separately disclosed.
us-gaap:PaymentsOfStockIssuanceCosts		xbrli:monetaryItemType	Duration	Credit
	The cash outflow for cost incurred directly with the issuance of an equity security.
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment		xbrli:monetaryItemType	Duration	Credit
	The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
us-gaap:PrepaidExpenseCurrent		xbrli:monetaryItemType	Instant	Debit
	Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
us-gaap:ProceedsFromIssuanceOfPrivatePlacement		xbrli:monetaryItemType	Duration	Debit
	The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.
us-gaap:ProceedsFromIssuanceOrSaleOfEquity		xbrli:monetaryItemType	Duration	Debit
	The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.
us-gaap:ProceedsFromNotesPayable		xbrli:monetaryItemType	Duration	Debit
	The cash inflow from a borrowing supported by a written promise to pay an obligation.
us-gaap:PropertyPlantAndEquipmentAbstract		xbrli:stringItemType	Duration	—

us-gaap:PropertyPlantAndEquipmentNet		xbrli:monetaryItemType	Instant	Debit
	Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
us-gaap:PropertyPlantAndEquipmentOther		xbrli:monetaryItemType	Instant	Debit
	Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.
us-gaap:PropertyPlantAndEquipmentPolicyTextBlock		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.
us-gaap:ReceivablesPolicyTextBlock		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy for trade and other accounts receivable, and finance, loan and lease receivables, including those classified as held for investment and held for sale. This disclosure may include (1) the basis at which such receivables are carried in the entity's statements of financial position (2) how the level of the valuation allowance for receivables is determined (3) when impairments, charge-offs or recoveries are recognized for such receivables (4) the treatment of origination fees and costs, including the amortization method for net deferred fees or costs (5) the treatment of any premiums or discounts or unearned income (6) the entity's income recognition policies for such receivables, including those that are impaired, past due or placed on nonaccrual status and (7) the treatment of foreclosures or repossessions (8) the nature and amount of any guarantees to repurchase receivables.
us-gaap:ResearchAndDevelopmentExpense		xbrli:monetaryItemType	Duration	Debit
	The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
us-gaap:RetainedEarningsMember		nonnum:domainItemType	Duration	—
	The cumulative amount of the reporting entity's undistributed earnings or deficit.
us-gaap:RevenueRecognitionPolicyTextBlock		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
us-gaap:Revenues		xbrli:monetaryItemType	Duration	Credit
	Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock		nonnum:textBlockItemType	Duration	—
	Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
us-gaap:ScheduleOfDebtInstrumentsTextBlock		nonnum:textBlockItemType	Duration	—
	Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.
us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock		nonnum:textBlockItemType	Duration	—
	Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock		nonnum:textBlockItemType	Duration	—
	Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock		nonnum:textBlockItemType	Duration	—
	Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock		nonnum:textBlockItemType	Duration	—
	Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
us-gaap:SellingGeneralAndAdministrativeExpense		xbrli:monetaryItemType	Duration	Debit
	The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock		nonnum:textBlockItemType	Duration	—
	The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details.
us-gaap:SignificantAccountingPoliciesTextBlock		nonnum:textBlockItemType	Duration	—
	The entire disclosure for all significant accounting policies of the reporting entity.
us-gaap:StatementEquityComponentsAxis		xbrli:stringItemType	Duration	—
	Information by component of equity.
us-gaap:StatementOfCashFlowsAbstract		xbrli:stringItemType	Duration	—

us-gaap:StatementOfFinancialPositionAbstract		xbrli:stringItemType	Duration	—

us-gaap:StatementOfStockholdersEquityAbstract		xbrli:stringItemType	Duration	—

us-gaap:StockIssuedDuringPeriodSharesNewIssues		xbrli:sharesItemType	Duration	—
	Number of new stock issued during the period.
us-gaap:StockIssuedDuringPeriodValueNewIssues		xbrli:monetaryItemType	Duration	Credit
	Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
us-gaap:StockIssuedDuringPeriodValueOther		xbrli:monetaryItemType	Duration	Credit
	Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.
us-gaap:StockholdersEquity		xbrli:monetaryItemType	Instant	Credit
	Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
us-gaap:StockholdersEquityAbstract		xbrli:stringItemType	Duration	—

us-gaap:StockholdersEquityNoteDisclosureTextBlock		nonnum:textBlockItemType	Duration	—
	The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
us-gaap:SubsequentEventsTextBlock		nonnum:textBlockItemType	Duration	—
	The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
us-gaap:SupplementalCashFlowInformationAbstract		xbrli:stringItemType	Duration	—

us-gaap:UseOfEstimates		nonnum:textBlockItemType	Duration	—
	Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
us-gaap:WeightedAverageBasicSharesOutstandingProForma		xbrli:sharesItemType	Duration	—
	The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted		xbrli:sharesItemType	Duration	—
	Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
Total Elements					146
Total Non-Abstract Elements					114
Total Extension Elements					1
Percent Extended					0%
Percent Extended (excluding abstracts)					0%

(End Elements)